Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels-Henrik Jensen

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|June 14, 2006
[Treatment of chronic pain--an underprioritized task for the society]Niels-Henrik Jensen, Søren Frølich
Ugeskrift for Laeger|November 22, 2007
[Pain relief]Lena E Lundorff, Niels-Henrik Jensen
Pain|November 1, 1994
Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonistsPer Sjøgren, Niels-Henrik Jensen, Troels Staehelin Jensen
Ugeskrift for Laeger|June 22, 2011
[Tapentadol is a new, strongly efficative analgeticum with dual effect mechanisms]Camilla Staahl, Asbjørn Mohr Drewes, Niels-Henrik Jensen
Scandinavian Journal of Pain|June 20, 2018
Long-term outcome of multidisciplinary intervention of chronic non-cancer pain patients in a private settingVilly Meineche-Schmidt, Niels-Henrik Jensen, Per Sjøgren
Journal of Pain & Palliative Care Pharmacotherapy|December 3, 2003
A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer painAndreas Frei, Steen Andersen, Peter Hole, et al.
Ugeskrift for Laeger|December 9, 2009
[Rejoiner to debate]Lona L Christrup, Niels-Henrik Jensen, Torsten Jonsson, et al.
Ugeskrift for Laeger|October 30, 2009
[The Danish Medicines Agency should reconsider the criteria of generic substitution between fentanyl depot patches]Lona L Christrup, Niels-Henrik Jensen, Torsten Jonsson, et al.
European Journal of Pain (London, England)|April 28, 2004
Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant painGertrud Andersen, Per Sjøgren, Steen Honoré Hansen, et al.
Journal of Pain and Symptom Management|February 15, 2002
Changing M3G/M6G ratios and pharmacodynamics in a cancer patient during long-term morphine treatmentGertrud Andersen, Lona L Christrup, Per Sjøgren, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|June 14, 2006
[Treatment of chronic pain--an underprioritized task for the society]Niels-Henrik Jensen, Søren Frølich
Ugeskrift for Laeger|November 22, 2007
[Pain relief]Lena E Lundorff, Niels-Henrik Jensen
Pain|November 1, 1994
Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonistsPer Sjøgren, Niels-Henrik Jensen, Troels Staehelin Jensen
Ugeskrift for Laeger|June 22, 2011
[Tapentadol is a new, strongly efficative analgeticum with dual effect mechanisms]Camilla Staahl, Asbjørn Mohr Drewes, Niels-Henrik Jensen
Scandinavian Journal of Pain|June 20, 2018
Long-term outcome of multidisciplinary intervention of chronic non-cancer pain patients in a private settingVilly Meineche-Schmidt, Niels-Henrik Jensen, Per Sjøgren
Journal of Pain & Palliative Care Pharmacotherapy|December 3, 2003
A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer painAndreas Frei, Steen Andersen, Peter Hole, et al.
Ugeskrift for Laeger|December 9, 2009
[Rejoiner to debate]Lona L Christrup, Niels-Henrik Jensen, Torsten Jonsson, et al.
Ugeskrift for Laeger|October 30, 2009
[The Danish Medicines Agency should reconsider the criteria of generic substitution between fentanyl depot patches]Lona L Christrup, Niels-Henrik Jensen, Torsten Jonsson, et al.
European Journal of Pain (London, England)|April 28, 2004
Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant painGertrud Andersen, Per Sjøgren, Steen Honoré Hansen, et al.
Journal of Pain and Symptom Management|February 15, 2002
Changing M3G/M6G ratios and pharmacodynamics in a cancer patient during long-term morphine treatmentGertrud Andersen, Lona L Christrup, Per Sjøgren, et al.
Pageof 2